Acutus Medical $77 million follow-on offering
We advised Acutus Medical on the SEC-registered stock offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Sight Sciences $276 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
IVERIC bio $115.2 million stock offering
We advised the underwriters on the SEC-registered equity offering
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
IDEAYA Biosciences $92 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
Aligos Therapeutics $83.6 million follow-on offering
We advised the underwriters on the stock offering
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
HUTCHMED HK$4.17 billion IPO and primary listing
The shares are listed on the Hong Kong Stock Exchange
GH Research $184 million IPO
We advised GH Research on the IPO and Nasdaq Listing
Theravance Biopharma $100.5 million follow-on offering
We advised the underwriters on the equity offering